Literature DB >> 34089360

Current update on malignant epithelial ovarian tumors.

Sherif B Elsherif1,2, Priya R Bhosale3, Chandana Lall4, Christine O Menias5, Malak Itani6, Kristina A Butler7, Dhakshinamoorthy Ganeshan3.   

Abstract

Epithelial ovarian cancer (EOC) represents the most frequently occurring gynecological malignancy, accounting for more than 70% of ovarian cancer deaths. Preoperative imaging plays an important role in assessing the extent of disease and guides the next step in surgical decision-making and operative planning. In this article, we will review the multimodality imaging features of various subtypes of EOC. We will also discuss the role of imaging in the staging, management, and surveillance of EOC.

Entities:  

Keywords:  Endometrioid carcinoma; Epithelial ovarian cancer; High-grade serous ovarian cancer; Low-grade serous ovarian cancer; Magnetic resonance imaging; Ovarian neoplasms

Mesh：

Year:  2021        PMID： 34089360     DOI： 10.1007/s00261-021-03081-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  73 in total

Review 1.  Diagnosis and Treatment of Ovarian Cancer.

Authors:  Brian Orr; Robert P Edwards
Journal:  Hematol Oncol Clin North Am       Date:  2018-12       Impact factor: 3.722

2.  CT and MRI findings of type I and type II epithelial ovarian cancer.

Authors:  Dong Liu; Lin Zhang; Nekitsing Indima; Kun Peng; Qianyu Li; Ting Hua; Guangyu Tang
Journal:  Eur J Radiol       Date:  2017-03-11       Impact factor: 3.528

Review 3.  Ovarian Cancer Genetics and Implications for Imaging and Therapy.

Authors:  Sherif B Elsherif; Silvana C Faria; Chandana Lall; Revathy Iyer; Priya R Bhosale
Journal:  J Comput Assist Tomogr       Date:  2019 Nov/Dec       Impact factor: 1.826

4.  Comparison between types I and II epithelial ovarian cancer using histogram analysis of monoexponential, biexponential, and stretched-exponential diffusion models.

Authors:  Feng Wang; Yuxiang Wang; Yan Zhou; Congrong Liu; Lizhi Xie; Zhenyu Zhou; Dong Liang; Yang Shen; Zhihang Yao; Jianyu Liu
Journal:  J Magn Reson Imaging       Date:  2017-04-05       Impact factor: 4.813

5.  ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer.

Authors:  Stella K Kang; Caroline Reinhold; Mostafa Atri; Carol B Benson; Priyadarshani R Bhosale; Anuja Jhingran; Yulia Lakhman; Katherine E Maturen; Refky Nicola; Pari V Pandharipande; Gloria M Salazar; Thomas D Shipp; Lynn Simpson; William Small; Betsy L Sussman; Jennifer W Uyeda; Darci J Wall; Bradford P Whitcomb; Carolyn M Zelop; Phyllis Glanc
Journal:  J Am Coll Radiol       Date:  2018-05       Impact factor: 5.532

Review 6.  Low-grade epithelial ovarian cancer: what a radiologist should know.

Authors:  Sherif Elsherif; Sanaz Javadi; Chitra Viswanathan; Silvana Faria; Priya Bhosale
Journal:  Br J Radiol       Date:  2019-01-31       Impact factor: 3.039

7.  Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.

Authors:  Mauro Signorelli; Luca Guerra; Cecilia Pirovano; Cinzia Crivellaro; Robert Fruscio; Alessandro Buda; Marco Cuzzucrea; Federica Elisei; Lorenzo Ceppi; Cristina Messa
Journal:  Gynecol Oncol       Date:  2013-08-27       Impact factor: 5.482

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 9.  Current state of biomarkers in ovarian cancer prognosis.

Authors:  Katrina K Au; Juliana A Josahkian; Julie-Ann Francis; Jeremy A Squire; Madhuri Koti
Journal:  Future Oncol       Date:  2015-11-09       Impact factor: 3.404

10.  Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients.

Authors:  Kyung Jin Eoh; Hyung Seok Park; Ji Soo Park; Seung-Tae Lee; Jeongwoo Han; Jung-Yun Lee; Sang Wun Kim; Sunghoon Kim; Young Tae Kim; Eun Ji Nam
Journal:  Cancer Res Treat       Date:  2016-07-27       Impact factor: 4.679
View more
  4 in total

1.  The Value of Magnetic Resonance Diffusion-Weighted Imaging and Dynamic Contrast Enhancement in the Diagnosis and Prognosis of Treatment Response in Patients with Epithelial Serous Ovarian Cancer.

Authors:  Pawel Derlatka; Laretta Grabowska-Derlatka; Marta Halaburda-Rola; Wojciech Szeszkowski; Krzysztof Czajkowski
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

2.  N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer.

Authors:  Xin Nie; Jichun Tan
Journal:  Hereditas       Date:  2022-03-18       Impact factor: 3.271

3.  Acylglycerol kinase promotes ovarian cancer progression and regulates mitochondria function by interacting with ribosomal protein L39.

Authors:  Fei Sun; Yunjian Wei; Zheng Liu; Qiuling Jie; Xiaohui Yang; Ping Long; Jun Wang; Ying Xiong; Qi Li; Song Quan; Yanlin Ma
Journal:  J Exp Clin Cancer Res       Date:  2022-08-08

4.  Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer.

Authors:  Sangsang Tang; Yuanming Shen; Xinyi Wei; Zhangjin Shen; Weiguo Lu; Junfen Xu
Journal:  Cell Death Dis       Date:  2022-09-27       Impact factor: 9.685
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.